2014-09-03 21:32:53 UTC

Gastroenterology Podcast September 2014: Vedolizumab for Crohn’s Patients After TNF Therapy Has Failed

A study in the September issue of Gastroenterology evaluated the effects of vedolizumab induction therapy for patients with Crohn’s disease for whom tumor necrosis factor (TNF) antagonists have already failed. Dr. Kuemmerle speaks with the first author of the study, Dr. Bruce E. Sands of the Ichan School of Medicine at Mount Sinai, New York; Plus, a rundown of top stories from this month's issue of GI and Hepatology News.

 

 

Sands BE, Feagan BG, Rutgeerts P, et al. Effects of Vedolizumab Induction Therapy for Patients With Crohn’s Disease in Whom Tumor Necrosis Factor Antagonist Treatment Failed. Gastroenterology 2014; September; 147(3): 618–627.e3
Abstract

 

 

Duration: 16.54m
Filetype: mp3
Bitrate: 96 KBPS
Frequency: 44100 HZ

More on Crohn's Disease

Digestive Disease Week® (DDW)

May 6, 2017

Digestive Disease Week® (DDW) is the premier meeting for the GI professional. Every year it attracts approximately 15,000 physicians, researchers and academics from around the world who desire to stay up-to-date in the field.

Announcing New Crohn’s & Colitis Congress

March 9, 2017

AGA and the Crohn’s & Colitis Foundation are joining together to put on a must-attend IBD conference January 2018 in Las Vegas.

AGA and Crohn’s & Colitis Foundation Announce Conference Partnership

March 9, 2017

Inaugural Crohn’s & Colitis Congress for health-care professionals and researchers to take place in Las Vegas in January 2018.